
Dolby Laboratories (NYSE:DLB – Free Report) – Research analysts at Zacks Research raised their Q3 2027 earnings per share estimates for Dolby Laboratories in a research report issued to clients and investors on Monday, November 16th. Zacks Research analyst Team now expects that the electronics maker will earn $0.58 per share for the quarter, up from their prior forecast of $0.57. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Dolby Laboratories’ current full-year earnings is $3.23 per share. Zacks Research also issued estimates for Dolby Laboratories’ FY2027 earnings at $3.20 EPS, Q1 2028 earnings at $0.66 EPS, Q2 2028 earnings at $0.92 EPS, Q3 2028 earnings at $0.87 EPS and FY2028 earnings at $3.40 EPS.
DLB has been the subject of a number of other research reports. Rosenblatt Securities decreased their price target on shares of Dolby Laboratories from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Monday. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $85.00.
Dolby Laboratories Stock Down 3.9%
Shares of DLB opened at $61.13 on Tuesday. The business’s fifty day moving average is $60.97 and its 200 day moving average is $59.43. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $69.95. The stock has a market cap of $5.73 billion, a P/E ratio of 26.01 and a beta of 0.79.
Institutional Investors Weigh In On Dolby Laboratories
Institutional investors have recently bought and sold shares of the stock. State of Michigan Retirement System lifted its stake in Dolby Laboratories by 1.4% during the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock valued at $883,000 after acquiring an additional 200 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al grew its stake in shares of Dolby Laboratories by 4.9% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 4,300 shares of the electronics maker’s stock worth $253,000 after acquiring an additional 200 shares in the last quarter. Frank Rimerman Advisors LLC raised its holdings in shares of Dolby Laboratories by 2.7% in the third quarter. Frank Rimerman Advisors LLC now owns 8,403 shares of the electronics maker’s stock valued at $494,000 after purchasing an additional 223 shares during the last quarter. CX Institutional raised its holdings in shares of Dolby Laboratories by 2.7% in the third quarter. CX Institutional now owns 13,074 shares of the electronics maker’s stock valued at $768,000 after purchasing an additional 347 shares during the last quarter. Finally, Sanctuary Advisors LLC raised its holdings in shares of Dolby Laboratories by 8.9% in the first quarter. Sanctuary Advisors LLC now owns 8,022 shares of the electronics maker’s stock valued at $482,000 after purchasing an additional 657 shares during the last quarter. Institutional investors own 58.56% of the company’s stock.
Insider Buying and Selling
In other news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the transaction, the senior vice president owned 166,803 shares in the company, valued at $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Ryan Nicholson sold 1,183 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the transaction, the chief accounting officer owned 34,453 shares in the company, valued at $2,249,091.84. This represents a 3.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 16,517 shares of company stock valued at $995,963 over the last three months. Corporate insiders own 37.93% of the company’s stock.
Dolby Laboratories declared that its board has authorized a share repurchase plan on Thursday, July 30th that permits the company to buy back $350 million in shares. This buyback authorization permits the electronics maker to repurchase up to 7% of its shares through open market purchases. Share buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.
Key Headlines Impacting Dolby Laboratories
These are some of the DLB headlines that stood out recently:
- Positive Sentiment: Zacks Research slightly raised its FY2027 and FY2028 earnings-per-share estimates to $3.20 and $3.40, respectively, and nudged up forecasts for several 2027–2028 quarters. These modest upgrades offer a favorable signal on expected earnings, though the firm maintains a Hold rating. Dolby Laboratories analyst coverage
- Neutral Sentiment: Rosenblatt Securities lowered its price target to $80 from $85 but kept a Buy rating. The revised target still indicates substantial upside relative to the cited $61.13 share price, while the cut tempers the otherwise positive view. Rosenblatt Securities ratings
- Neutral Sentiment: Dolby is scheduled to report quarterly results, putting the focus on its performance and outlook. The earnings-preview coverage provided no specific results or forecast that would point clearly in either direction. Dolby Laboratories earnings preview
Dolby Laboratories Company Profile
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
Read More
- Five stocks we like better than Dolby Laboratories
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
